Literature DB >> 9674394

Exaggerated arthropod-bite lesions in patients with chronic lymphocytic leukemia: a clinical, histopathologic, and immunopathologic study of eight patients.

M D Davis1, C Perniciaro, P R Dahl, H W Randle, M T McEvoy, K M Leiferman.   

Abstract

BACKGROUND: Unusual papulovesicular lesions resembling arthropod bites have been described in patients with chronic lymphocytic leukemia (CLL).
OBJECTIVE: Our purpose was to describe and characterize further the clinical, histopathologic, and immunopathologic features of these lesions.
METHODS: Eight patients were identified retrospectively who had CLL and characteristic skin lesions. Clinical and histologic features were recorded. Skin biopsy specimens were analyzed immunohistochemically for eosinophil granule major basic protein, eosinophil-derived neurotoxin, neutrophil elastase, and mast cell tryptase.
RESULTS: The clinical features, including the lesional distribution, suggested arthropod bites, although most patients could not recall having been bitten. Mixed T- and B-cell lymphoid cell infiltrates were present within lesions, along with prominent eosinophil infiltration and eosinophil granule protein deposition.
CONCLUSION: Exuberant papulovesicular lesions develop in patients with CLL apparently as an exaggerated response to arthropod bites. Prominent eosinophil infiltration and degranulation within these lesions likely contribute to the severity of symptoms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674394     DOI: 10.1016/s0190-9622(98)70398-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

Review 1.  Roles of the immune system in skin cancer.

Authors:  S Rangwala; K Y Tsai
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

2.  Mantle cell lymphoma presenting with exaggerated skin reaction to insect bites.

Authors:  Kavita Darji; Emily Bahram-Ahi; Maulik Dhandha; Mary Guo
Journal:  BMJ Case Rep       Date:  2019-03-21

3.  Eosinophilic panniculitis and insect bite-like eruption in a patient with chronic lymphocytic leukaemia: a spectrum of the same entity.

Authors:  R Rodríguez-Lojo; M Almagro; F Piñeyro; L Pérez-Varela; B Fernández-Jorge; J Del Pozo; F Sacristán; E Fonseca
Journal:  Dermatol Res Pract       Date:  2010-06-07

4.  Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?

Authors:  Jianjun Qiao; Chang-E Sun; Weifang Zhu; Dingxian Zhu; Hong Fang
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 5.  Targeting inflammatory pathways in chronic lymphocytic leukemia.

Authors:  Uri Rozovski; Michael J Keating; Zeev Estrov
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-12       Impact factor: 6.312

6.  Exaggerated cutaneous response to mosquito bites in a patient with chronic lymphocytic leukemia.

Authors:  Keiko Asakura; Masahiro Kizaki; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

7.  Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.

Authors:  Omar Bari; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2017-07-31

Review 8.  Skin: A mirror of internal malignancy.

Authors:  Rita V Vora; RahulKrishna S Kota; Nilofar G Diwan; Nidhi B Jivani; Shailee S Gandhi
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec

Review 9.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

10.  Hypersensitivity reaction to a mosquito bite in a patient with chronic myeloid leukemia.

Authors:  Uri P Dior; Shaden Salameh; Yonatan Gershinsky; Ruth Stalnikowicz
Journal:  Case Rep Emerg Med       Date:  2011-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.